FDA NDC Directory · JSON-LD · Markdown

Levothyroxine Sodium

NDC 42023-203 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameLEVOTHYROXINE SODIUM ANHYDROUS
Labeler / ManufacturerENDO USA, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA202231
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsLEVOTHYROXINE SODIUM ANHYDROUS (500 ug/5mL)
Marketing started20110624
Package count1

External sources

Source: openFDA. Public-domain (CC0).